SEC Filings

Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT^® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

Filing date	Form	Description	View
Dec 11, 2017	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-17-007604.pdf 0001047469-17-007604.rtf 0001047469-17-007604.xls
Dec 13, 2017	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-17-007654.pdf 0001047469-17-007654.rtf 0001047469-17-007654.xls
Mar 27, 2019	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-19-001686.pdf 0001047469-19-001686.rtf 0001047469-19-001686.xls
Mar 29, 2019	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-19-001772.pdf 0001047469-19-001772.rtf 0001047469-19-001772.xls
Jan 21, 2020	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-20-000348.pdf 0001047469-20-000348.rtf 0001047469-20-000348.xls
Jan 23, 2020	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-20-000448.pdf 0001047469-20-000448.rtf 0001047469-20-000448.xls
Jul 31, 2020	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001104659-20-089051.pdf 0001104659-20-089051.rtf 0001104659-20-089051.xls
Feb 17, 2022	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001104659-22-024510.pdf 0001104659-22-024510.rtf 0001104659-22-024510.xls
Feb 17, 2023	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001104659-23-023064.pdf 0001104659-23-023064.rtf 0001104659-23-023064.xls
Apr 30, 2015	424B4	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	View HTML 0001047469-15-004205.pdf 0001047469-15-004205.rtf 0001047469-15-004205.xls

Investors & Media

Transformative science, targeted medicines

SEC Filings

Pagination